Feb 1, 2020 - OnabotulinumtoxinA reduces the number of migraine days per month by two days compared with placebo in adults with chronic migraines.
American Family Physician : Cochrane for Clinicians
Apr 15, 2020 - In otherwise healthy adults with severe and frequent migraine or cluster headaches, galcanezumab may provide a modest reduction in debilitating headache frequency in the short term.
American Family Physician : STEPS
navigate_before 1 navigate_next